ADMA Biologics, Inc. (ADMA) vs Celldex Therapeutics, Inc. (CLDX)

A side-by-side comparison of ADMA Biologics, Inc. and Celldex Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ADMA vs CLDX

growth of $100 · dividends reinvested · last 10y
ADMA +50.9% (+4.2%/yr)CLDX -49.1% (-6.5%/yr)ADMA compounded faster over this window
0100200300Start $10020182020202220242026$151$51
ADMA CLDX

ADMA vs CLDX: by the numbers

  • •ADMA is the larger company ($2.34B vs $2.17B market cap).
  • •ADMA is profitable (32.98% net margin) while CLDX runs a net loss (-268385.71%).
  • •ADMA grew revenue faster over the past five years (54.55% vs -58.05% CAGR).

Metrics side by side

Valuation

MetricADMACLDX
P/E ratio14.44N/A
Forward P/E12.69N/A
P/S ratio4.5719361.50
P/B ratio5.743.03
EV / EBITDA10.67N/A
FCF yield4.97%N/A

Profitability

MetricADMACLDX
Gross margin64.71%100.00%
Operating margin42.26%-19160.00%
Net margin32.98%-268385.71%
ROE41.39%-42.07%
ROIC27.60%-45.19%

Growth (annualized)

MetricADMACLDX
Revenue CAGR (5Y)54.55%-58.05%
Total return CAGR (5Y)54.74%-10.28%

Frequently asked

Which has grown faster, ADMA or CLDX?
Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus CLDX at -58.05%.
Is ADMA or CLDX more profitable?
ADMA runs the higher net margin — ADMA at 32.98% versus CLDX at -268385.71%.
How have ADMA and CLDX total returns compared?
Over the past 10 years, ADMA delivered 3.85% and CLDX delivered -6.79% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.